More specifically, in 2017, McIntyre et al. detected ESR1 Y537S mutation in one patient with low-grade serous ovarian carcinoma, when analyzing 26 primary tumor samples using NGS [38]. This evidence concerns the gene ESR1 and ovarian serous carcinoma.